Cargando…
Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
Autores principales: | Teng, Chiao-Fang, Wang, Ting, Wu, Tzu-Hua, Lin, Jia-Hui, Shih, Fu-Ying, Shyu, Woei-Cherng, Jeng, Long-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640278/ https://www.ncbi.nlm.nih.gov/pubmed/34868354 http://dx.doi.org/10.1177/17588359211061902 |
Ejemplares similares
-
Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
por: Teng, Chiao-Fang, et al.
Publicado: (2020) -
Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant
por: Teng, Chiao-Fang, et al.
Publicado: (2020) -
Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy
por: Teng, Chiao-Fang, et al.
Publicado: (2018) -
Notices
Publicado: (2009) -
Notice
Publicado: (2013)